Dayton, Ohio-Dayton area residents may participate in an important clinical research study that will investigate and evaluate a topical medication for plaque psoriasis. The Division of Dermatology at Wright State University Boonshoft School of Medicine is one of a group of sites across the United States and Canada involved in the study.
The purpose of this study is to evaluate the safety and effectiveness of an investigational topical treatment for plaque psoriasis. This medication is believed to suppress the immune response in the area to which it is applied, thereby slowing the over-activity of cell growth in order to reduce inflammation.
Participation in this research study, led by Michael P. Heffernan, M.D., at the Boonshoft School of Medicine, Division of Dermatology, will involve as many as eight or nine office visits over a period of 4 months. People age 12 or above who have been diagnosed with psoriasis may be eligible to volunteer. Volunteers will receive study-related examinations, lab tests, and study-related medication. As many as nine million people in the U.S. and Canada have psoriasis, a chronic skin disease resulting in itchy, flaking, inflamed red patches on the skin. Psoriasis is not contagious; it is caused by an error in the body's immune response. During a flare-up of psoriasis, skin cells grow and age rapidly. For those with plaque psoriasis areas of rapid cell growth may start as small red spots, enlarging to become patches of inflamed, red, raised skin, covered with silvery scales, which flake, itch, and become sore.
Psoriasis most often appears between the age of 15 and 35, but can occur at any age. One-third of those with psoriasis have a family history of the condition. There is currently no cure for psoriasis. Treatments are aimed at reducing symptoms and improving the quality of life of individuals with the condition.
For more information about the psoriasis research study contact, Bina Rashid, M.D., at Wright State University's Division of Dermatology at (937) 224-1517 x103.
For more information, contact Public Relations.